Profile for ImmunoGen, Inc. (IMGN)
« Back to company indexIMGN Chatter Timeline
Stock Ticker for IMGN
Most Active Tweeters for IMGN
| User | Tweets |
|---|---|
| @WeekHerald | 6 |
| @registrarjourn | 5 |
| @dakotafinancial | 5 |
| @AmericanBanking | 5 |
| @ConsumerFeed | 4 |
Recent Tweets for IMGN
 |
@AlpacaAlerts $IMGN is in Three Outside Up winning 60.00% in the past. https://t.co/ep4N9x1BHK https://t.co/vQOOaAeuCI May 24th 2018, 10:05pm |
 |
@IlliniJJ $IMGN - seem to be the beginning of the runup to ASCO May 24th 2018, 4:05pm |
 |
@QuantchaIdeas Covered Call Alert: IMMUNOGEN $IMGN returning up to 22.49% through 19-Oct-2018 https://t.co/uyYX9XymcP https://t.co/N5kpIGHWRy May 23rd 2018, 12:05pm |
 |
@StockTexts $IMGN ImmunoGen, Inc. SEC Filing: Form CT ORDER https://t.co/thra2Ovw9S May 23rd 2018, 11:05am |
 |
@iamtito_ $IMGN - Confidential Treatment Order (ct Order) https://t.co/oMTL6trfGb May 23rd 2018, 11:05am |
 |
@dispatchtribune Critical Review: ImmunoGen $IMGN and AnaptysBio $ANAB https://t.co/kIevJ3jsVW May 22nd 2018, 1:05pm |
 |
@ThisLincolnian ImmunoGen $IMGN Given a $18.00 Price Target by HC Wainwright Analysts https://t.co/fA0AZ2FtTn May 21st 2018, 6:05am |
 |
@DrTranBioSci RT @SA_BioTech: $IMGN https://t.co/aO2lpb9CuJ May 21st 2018, 5:05am |
 |
@ConsumerFeed Cowen Reiterates “Hold” Rating for ImmunoGen $IMGN https://t.co/UnTU3QHauy May 21st 2018, 5:05am |
|
@ConsumerFeed ImmunoGen $IMGN Given a $18.00 Price Target by HC Wainwright Analysts https://t.co/wUtwMR2Qhr May 21st 2018, 2:05am |
|
@dispatchtribune ImmunoGen $IMGN Receives Average Rating of “Buy” from Analysts https://t.co/n78HxIJpRL May 20th 2018, 10:05pm |
 |
@WeekHerald ImmunoGen $IMGN Receives $13.60 Consensus Target Price from Analysts https://t.co/SFQe2rBpBP May 20th 2018, 10:05pm |
|
@ConsumerFeed Analyzing ImmunoGen $IMGN & AnaptysBio $ANAB https://t.co/S9ZeS7XfzO May 20th 2018, 10:05am |
 |
@OlympiaReport HC Wainwright Reiterates $18.00 Price Target for ImmunoGen $IMGN https://t.co/yuy81pabIl May 20th 2018, 10:05am |
|
@dispatchtribune HC Wainwright Analysts Give ImmunoGen $IMGN a $18.00 Price Target https://t.co/q7NDR1FGbB May 20th 2018, 10:05am |
 |
@TickerReport ImmunoGen $IMGN Stock Rating Reaffirmed by Cowen https://t.co/r5JQXz2d0X May 20th 2018, 10:05am |
 |
@registrarjourn Analyzing ImmunoGen $IMGN & AnaptysBio $ANAB https://t.co/ghNg3DKQm1 May 20th 2018, 10:05am |
|
@WeekHerald HC Wainwright Analysts Give ImmunoGen $IMGN a $18.00 Price Target https://t.co/zjxq80so8l May 20th 2018, 7:05am |
 |
@TranscriptDaily HC Wainwright Analysts Give ImmunoGen $IMGN a $18.00 Price Target https://t.co/vntHkgBKLm May 19th 2018, 11:05am |
 |
@dailypoliticaln ImmunoGen $IMGN Rating Reiterated by Cowen https://t.co/hI4IGEsTIa May 19th 2018, 11:05am |
 |
@ZolmaxNews ImmunoGen $IMGN Earns Hold Rating from Cowen https://t.co/ZZVjiOHHeM May 19th 2018, 11:05am |
 |
@dakotafinancial ImmunoGen $IMGN Receives $13.60 Consensus Price Target from Analysts https://t.co/GjskKEhQbm May 18th 2018, 6:05pm |
 |
@SeekingAlpha $IMGN https://t.co/hAloNBHGX8 May 18th 2018, 2:05pm |
 |
@SA_BioTech $IMGN https://t.co/aO2lpb9CuJ May 18th 2018, 2:05pm |
|
@dakotafinancial Cowen Reiterates Hold Rating for ImmunoGen $IMGN https://t.co/5ByEqEwY1y May 18th 2018, 12:05pm |
 |
@WatchlistN ImmunoGen $IMGN PT Set at $18.00 by HC Wainwright https://t.co/PTeWkPOqKg May 18th 2018, 12:05pm |
|
@WeekHerald ImmunoGen $IMGN Receives Hold Rating from Cowen https://t.co/nNmq7Am5n8 May 18th 2018, 12:05pm |
|
@QuantchaIdeas Covered Call Alert: IMMUNOGEN $IMGN returning up to 16.82% through 19-Oct-2018 https://t.co/oAIUEagBgG https://t.co/nXRwxyH9Ds May 18th 2018, 12:05pm |
|
@WeekHerald Critical Comparison: ImmunoGen $IMGN versus AnaptysBio $ANAB https://t.co/F0NsvYY8QS May 18th 2018, 7:05am |
|
@dakotafinancial AnaptysBio $ANAB versus ImmunoGen $IMGN Financial Comparison https://t.co/4ZyLVoFhwL May 18th 2018, 4:05am |
 |
@stockmktgenius $IMGN ImmunoGen, Inc. - Common #LeaderPullBack Close: 10.76 Liq: $44M https://t.co/u74b0PuX1u May 17th 2018, 6:05pm |
 |
@AmericanBanking Cowen Reaffirms “Hold” Rating for ImmunoGen $IMGN https://t.co/1DkYqQAa5n #stocks May 17th 2018, 4:05pm |
 |
@MaisaCorp $IMGN announcing positive findings from the FORWARD II trial of mirvetuximab soravtansine combination regimens wit… https://t.co/ErBDHAVhfp May 17th 2018, 3:05pm |
|
@AmericanBanking ImmunoGen $IMGN PT Set at $18.00 by HC Wainwright https://t.co/Fh67NprlTT #stocks May 17th 2018, 3:05pm |
 |
@ARatings Analysts Conflicted on These Healthcare Names: ImmunoGen (NASDAQ: IMGN) and Agios Pharma (NASDAQ: AGIO) $IMGN https://t.co/DHvEiQXq6M May 17th 2018, 2:05pm |
|
@dailypoliticaln ImmunoGen $IMGN PT Set at $18.00 by HC Wainwright https://t.co/BrPRpnU6XE May 17th 2018, 1:05pm |
|
@TickerReport ImmunoGen $IMGN PT Set at $18.00 by HC Wainwright https://t.co/OsMWchcNgi May 17th 2018, 1:05pm |
 |
@MarketCurrents ImmunoGen's mirventuximab soravtansine shows positive effect in early-stage ovarian cancer study https://t.co/goqQ0BWsz5 $IMGN May 17th 2018, 1:05pm |
 |
@Turtle_Traders $IMGN 60min; ??? https://t.co/RHXZobPnss May 17th 2018, 9:05am |
 |
@1MinuteStock Btw, Estimated #Earnings Per Share for $IMGN is $-0.24 it's -2.23% of the current price https://t.co/sCUusTbUzB May 17th 2018, 8:05am |
 |
@Stock_News_Now $IMGN: New SEC Filing for IMGN: Form 8-K (No. 0001104659-18-033970): https://t.co/kke5lJOLS2 May 17th 2018, 8:05am |
|
@StockTexts $IMGN ImmunoGen, Inc. SEC Filing: Form 8-K https://t.co/AEeIl6efWE May 17th 2018, 7:05am |
|
@iamtito_ $IMGN - Current Report Filing (8-k) https://t.co/PD9VnZxDOt May 17th 2018, 7:05am |
|
@ZolmaxNews ImmunoGen $IMGN Expected to Post Quarterly Sales of $14.15 Million https://t.co/N7FSRQZ9by May 16th 2018, 9:05pm |
|
@dailypoliticaln Analysts Anticipate ImmunoGen $IMGN Will Post Quarterly Sales of $14.15 Million https://t.co/mNkHVwdgMk May 16th 2018, 9:05pm |
|
@ThisLincolnian Analysts Anticipate ImmunoGen $IMGN Will Post Quarterly Sales of $14.15 Million https://t.co/RIxxRE68hg May 16th 2018, 9:05pm |
 |
@MindMakesMatter $IMGN Anyone know if the chain is shit? https://t.co/cuapn3h3W6 May 16th 2018, 7:05pm |
 |
@Briefingcom $IMGN: ImmunoGen announces positive findings from the FORWARD II Study of mirvetuximab soravtansine combination... https://t.co/vh7GuFCE1N May 16th 2018, 7:05pm |
 |
@surveyist RT @odibro: $IMGN Announces Positive Findings from the FORWARD II Study of Mirvetuximab Soravtansine Combination Regimens with Avastin® and… May 16th 2018, 6:05pm |
|
@stockmktgenius $IMGN ImmunoGen, Inc. - Common #LeaderPullBack Close: 10.77 Liq: $17M https://t.co/u74b0PuX1u May 16th 2018, 6:05pm |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.